EBM Technologies Incorporated (TPEX:8409)
Taiwan · Delayed Price · Currency is TWD 17.90
-0.10 (-0.56%)
Oct 8, 2026, 11:47 AM CST
EBM Technologies Market Cap
EBM Technologies has a market cap or net worth of 572.8 million as of October 9, 2026. It is the 37,939th most valuable company in the world and the 2,242nd biggest in Taiwan. Its market cap has decreased by 29.39% in one year.
Market Cap
572.80M
Enterprise Value
512.66M
Revenue
283.73M
Global Rank
Country Rank
#2,242 Taiwan
PE Ratio
17.61
ChartMarket Cap Chart
Since April 13, 2010, EBM Technologies's market cap has decreased from 882.35M to 572.80M, a decrease of -35.08%. That is a compound annual growth rate of -2.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 572.80M | -17.70% |
| Dec 31, 2025 | 696.00M | -7.45% |
| Dec 31, 2024 | 752.00M | -6.00% |
| Dec 29, 2023 | 800.00M | 31.93% |
| Dec 30, 2022 | 606.40M | 6.16% |
| Dec 30, 2021 | 571.20M | 11.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 495.25B |
| Caliway Biopharmaceuticals | 120.54B |
| Lin BioScience | 104.13B |
| Heron Neutron Medical | 81.84B |
| Carilex Medical | 651.76M |
| Meribank Biotech | 649.74M |
| Perfect Medical Industry | 647.23M |
| SynCore Biotechnology Co.,Ltd | 632.97M |